Hospital Rijnstate

Arnhem 6815 AD

0 studies enrolling now · 2 studies all time

What they study most

Atrial Fibrillation, Follicular Lymphoma, Marginal Zone Lymphoma, Stroke

Studies at this site

• A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. — Running, not enrolling
• Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation — Completed